References
- Shaya FT, Samant S. Formulary decision methodology in the context of health system costs and insurance trends. Expert Rev. Pharmacoeconomics Outcomes Res. 4(6), 595–597 (2004).
- Shaya FT, Samant S. Cost studies in clinical trials. Expert Rev. Pharmacoeconomics Outcomes Res. 4(6), 591–594 (2004).
- Murphy J, Coster G. Issues in patient compliance. Drugs 54(6), 797–800 (1997).
- Rhee MK, Slocum W, Ziemer DC et al. Patient adherence improves glycemic control. Diabetes Educ. 31(2), 240–250 (2005).
- Fedder DO. Managing medication and compliance: physician–pharmacist–patient interaction. J. Am. Geriatr. Soc. 30, S113–S117 (1982).
- Sackett DL, Snow JC. The magnitude of compliance and non-compliance. In: Compliance in Healthcare. Haynes RB, Taylor DW, Sackett DL (Eds), John Hopkins University Press, MD, USA, 11–22 (1979).
- Horowitz RI, Horowitz SM. Adherence to treatment and health outcomes. Arch. Int. Med 153, 1863–1868 (1993).
- Noe L, Sneeringer R, Patel B, Williamson T. The implications of poor medication persistence with treatment for overactive bladder. Manage. Care Interface 17(11), 54–60 (2004).
- Schwartz GF. Measuring persistency with drug therapy in glaucoma management. Am. J. Manag. Care 8(10), S237–S239 (2002).
- Misselbrook D. Managing the change from compliance to concordance. Prescriber 9(8), 23–33 (1998).
- Hope C, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am. J. Health-Syst. Pharm. 61, 2043–2049 (2004).
- Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am. J. Manag. Care 10, 144–151 (2004).
- Garcia R, Schooley RT, Badaro R. An adherence trilogy is essential for long-term HAART success. Braz. J. Infect. Dis. 7(5), 307–314 (2003).
- Connor J, Rafter N, Rodger A. Do fixed-dose combination pills or unit packaging improve adherence? A systematic review. Bulletin of the World Health Organization 82(12), 935–939 (2004).
- Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am. J. Public Health 94(10), 1782–1787 (2004).
- Bayliss EA, Park MK, Westfall JM, Zamorski MA. Clinical inquiries. How can I improve patient adherence to prescribed medication? J. Family Practice 50(4), 303–304 (2001).
- Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J. Clin. Epidemiol. 57, 1107–1110 (2004).
- Rubin R. Adherence to pharmacologic therapy in patients with Type 2 diabetes mellitus. Am. J. Med. 118(5A), S27–S34 (2005).
- Schectman JM, Nadkarni NM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25, 1015–1021 (2002).
- Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 27, 1218–1224 (2004).
- Giannetti VJ. Adherence with antidepressant medication. Manag. Care 13(Suppl. 6), 42–47 (2004).
- Sleath B, Rubin RH, Wurst K. The influence of Hispanic ethnicity on patients’ expression of complaints about and problems with adherence to antidepressant therapy. Clin. Ther. 25(6), 1739–1749 (2003).
- Aikens JE, Nease DE, Nau DP et al. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann. Fam. Med. 3(1), 23–30 (2005).
- Weinstein AG. Should patients with persistent severe asthma be monitored for medication adherence? Ann. Allergy Asthma Immunol. 94(2), 251–257 (2005).
- Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 114(6), 1288–1293 (2004).
- Hernandez DV, Schmaling KB. Understanding and resolving adherence problems. Clin. Rev. Allergy Immunol. 27(2), 65–73 (2004).
- Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J. Cardiovasc. Pharmacol. 35(Suppl. 3), S23–S26 (2000).
- Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur. J. Cardiovasc. Nurs. 2(3), 219–228 (2003).
- Hamann GF, Weimar C, Glahn J et al. Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank. Cerebrovasc. Dis. 15(4), 282–288 (2003).
- Ovbiagele B, Saver JL, Fredieu A et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 35(12), 2879–2883 (2004).
- Kopjar B, Sales AE, Pineros SL et al. Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population. Am. J. Cardiol. 92(9), 1106–1108 (2003).
- Cheng CW, Woo KS, Chan JC et al. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. Br. J. Clin. Pharmacol. 58(5), 528–535 (2004).
- Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ. 21, 52–57 (1995).
- Matsuyama JR, Mason BJ, Jue SG. Pharmacists’ interventions using electronic medication-event monitoring device’s adherence data versus pill counts. Ann. Pharmacother. 27, 851–855 (1993).
- Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 20, 1512–1517 (1997).
- Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Neuropsychological correlates of suboptimal adherence to metformin. J. Behav. Med. 26, 349–360 (2003).
- Morningstar BA, Sketris IS, Kephart GC, Sclar DA. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycemic drug therapy in seniors in Nova Scotia, Canada. J. Clin. Pharm. Ther. 27, 213–220 (2002).
- Evans JM, Donnan PT, Morris AD. Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes. Diabet. Med. 19, 685–688 (2002).
- Melikian C, White TJ, Vanderplas A, Dezeii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin. Ther. 24, 460–467 (2002).
- Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization a pharmacy record-based study. Ann. Pharmacother. 33, 281–288 (1999).
- Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycemic drug regimens evaluation of a Medicaid population with Type 2 diabetes mellitus. Clin. Ther. 23, 1311–1320 (2001).
- Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes a retrospective cohort study. Diabet. Med. 19, 279–284 (2002).
- Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for Type 2 diabetes. South Med. J. 95, 68–71 (2002).
- Hansen BE. Sample splitting and threshold estimation. Econometrica 68, 575–603 (2005).
Website
- Warner J. Drug safety at the FDA under fire: What to do? WebMD Health 2004 webcenter.health.webmd.netscape.com/ content/Article/97/104178.htm (Accessed May 2005)